PCR直接测序法检测宫颈癌组织中人乳头瘤病毒DNA

南方医科大学学报 ›› 2005, Vol. 25 ›› Issue (02): 201-203.

PCR直接测序法检测宫颈癌组织中人乳头瘤病毒DNA

刘欣¹, 刘国炳¹, 庞战军¹, 邢福祺¹, 郭遂群¹, 马文丽², 郑文岭²

1. 南方医科大学南方医院妇产科, 广东, 广州, 510515;
2. 南方医科大学分子生物学研究所, 广东, 广州, 510515

出版日期:2005-02-20 发布日期:2005-02-20
基金资助:
收稿日期:2004-8-11。
基金项目:南方医院2002年新技术新业务课题
作者简介:刘欣(1975- ),女,1998年毕业于同济医科大学,在读硕士研究生,电话:020-61365788,E-mail:liuxin23@fimmu.com

Detection of human papillomavirus DNA in cervical cancer tissue by PCR and direct sequencing

LIU Xin¹, LIU Guo-bing¹, PANG Zhan-jun¹, XING Fu-qi¹, GUO Sui-qun¹, MA Wen-li², ZHENG Wen-ling²

1. 南方医科大学南方医院妇产科, 广东, 广州, 510515;
2. 南方医科大学分子生物学研究所, 广东, 广州, 510515

Online:2005-02-20 Published:2005-02-20

摘要/Abstract

摘要： 目的探索检测宫颈癌组织中人乳头瘤病毒(HPV)DNA的有效手段。方法采用HPV通用引物对宫颈癌标本中的HPVL1区基因序列进行PCR扩增,根据PCR产物序列分析对HPV分型。结果 50例宫颈癌组织HPVDNA检出率为78%,其中HPV16和HPV18型混合感染最多见。检测出1例HPV58型,其L1区基因序列与德国标准株58型比对,未发现碱基变异。结论 PCR直接测序法是对宫颈癌组织中HPV检测和分型的一种有效方法,并可检测到HPV少见的特殊类型,同时也能提供已知的HPV型别的突变信息。

Abstract: Objective To explore an effective method for detecting human papillomavirus(HPV) DNA in cervical cancer tissue. Methods HPV L1 gene fragment in cervical cancer tissue was amplified by HPV-specific PCR with consensus primers, and typing of the HPV strains was performed on the basis of sequence analysis of the PCR product. Results The positivity rates of HPV DNA was 78% in the 50 cases of cervical cancer, and mixed infection with HPV16 and HPV18 strains was the most common, which accounted for 48% on the total infections. Infection with HPV58 was detected in one case. The sequencing results showed no difference in L1 sequence between the detected samples and the standard German HPV58 strain. Conclusion PCR and direct sequencing approach is effective for detecting and typing of HPV DNA in cervical cancer tissue, through which rare HPV strain or mutants of known HPV strains may not escape detection.

中图分类号:

R373.9

刘欣¹, 刘国炳¹, 庞战军¹, 邢福祺¹, 郭遂群¹, 马文丽², 郑文岭². PCR直接测序法检测宫颈癌组织中人乳头瘤病毒DNA[J]. 南方医科大学学报, 2005, 25(02): 201-203.

LIU Xin¹, LIU Guo-bing¹, PANG Zhan-jun¹, XING Fu-qi¹, GUO Sui-qun¹, MA Wen-li², ZHENG Wen-ling². Detection of human papillomavirus DNA in cervical cancer tissue by PCR and direct sequencing[J]. Journal of Southern Medical University, 2005, 25(02): 201-203.

参考文献

[1] Bosch FX, Lorincz A, Munoz N, et al. The causal relation betweenhuman papillomavirus and cervical cancer[J]. J Clin Pathol, 2002, 55(4): 244-65.
[2] Bosch FX, Rohan T, Schnieder A, et al. Papillomavirus research update: Highlights of the Barcelona HPV 2000 international papillomavirus conference[J]. J Clin Pathol, 2001, 54(3): 163-75.
[3] Lobbard I, Vincent Salomon A, Validire P, et al. Human papillo mavirus genotype as a major determinant of the course of cervical cancer[J]. Clin Oncol, 1998, 169(7): 2613-9.
[4] McLachlin CM. Human papillomavirus in cervical neoplasia. Role,risk factors and implications[J]. Clin Lab Med, 2000, 20(2): 257-70.
[5] Juan C, Feoli-Fonseca JC, Luc L, et al. Human papillomavirus study of 691 pathological specimens from Quebec by PCR-direct sequencing approach[J]. J Med Virol, 2001, 63(4): 284-92.
[6] Walboomers JM, Jaclbs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide [J]. J Pathol, 1999, 189(1): 12-9.
[7] Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective [J]. J Natl Cancer Ins, 1995, 87(1 1): 796-802.
[8] 丁守怡,吴荣原位杂交测肿瘤坏死因子mRNA在宫颈细胞及子宫内膜组织的定位表达[J].第一军医大学学报,2002,22(3):244-6.Ding SY, Wu R. Detection of tumor necrosis factor mRNA expres sion in human cervix and endometrium by in situ hybridization [J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2002, 22(3): 244-6.
[9] Rower D, Lacey C. Toward a human papilloma virus vaccine [J]. Dermatol Clin, 1998, 16(4): 835-8.
[10] 刘翠华,马文丽,石嵘,等.Agilent 2100 Bioanalyzer在人乳头瘤病毒检测中的应用[J].第一军医大学学报,2003,23(3):213-5.Liu CH, Ma WL, Shi R, et al. Application of Agilent 2100 Bioanalyzer in detection of human papilloma virus [J]. J First Mil Med Univ/Di Yi Jun Yi Da Xue Xue Bao, 2003, 23(3): 213-5.